Dosing question : r/tirzepatidecompound
US$ 24.38
micro dose glp-1 peptide GLP‑1 Microdosing Houston Microdosing GLP-1 Medications | Achieve
Description
Phase 2: Momentum Weeks 13-24 Side effects minimal
BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy
Hosted by Ahmar U
Rosi = rosiglitazone
